Berberine alleviates amyloid β25‑35‑induced inflammatory response in human neuroblastoma cells by inhibiting proinflammatory factors

Xu,Jing; Wu,Wenlan; Zhang,Hong; Yang,Li

doi:10.3892/etm.2018.6749

Berberine alleviates amyloid β25‑35‑induced inflammatory response in human neuroblastoma cells by inhibiting proinflammatory factors

Authors:
- Jing Xu
- Wenlan Wu
- Hong Zhang
- Li Yang
View Affiliations

Affiliations: Department of Geriatrics, The Affiliated Drum Tower Hospital of Medical School of Nanjing University, Nanjing, Jiangsu 210008, P.R. China, Department of Head and Neck Surgery, Jiangsu Cancer Hospital, Nanjing, Jiangsu 210008, P.R. China
Published online on: September 17, 2018 https://doi.org/10.3892/etm.2018.6749
Pages: 4865-4872

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study investigated the effect of berberine (BBR) on amyloid β 25‑35 (Aβ25‑35)‑induced inflammatory response in human neuroblastoma cells. To model the inflammatory response observed in the central nervous system of patients with Alzheimer's disease, SH‑SY5Y and SK‑N‑SH neuroblastoma cells were induced by Aβ25‑35 (5 µM) for 24 h. Subsequently, cells were treated with BBR or indomethacin for 2 h. The cell survival rate was determined by the MTT assay. The activity of lactate dehydrogenase (LDH) in the cell culture medium was examined by spectrophotometry. The expression levels of inflammatory factors prostaglandin E2 (PGE2) and tumor necrosis factor‑α (TNF‑α) were determined by ELISA assays. The mRNA and protein expression levels of interleukin (IL)‑1β, cyclooxygenase 2 (COX‑2) and tumor necrosis factor receptor 1 (TNFR1) were measured by reverse‑transcription‑quantitative polymerase chain reaction and Western blotting, respectively. The results indicated that, treatment with Aβ25‑35 increased the expression levels of PGE2 and TNF‑α, increased the activity of LDH, and up‑regulated the mRNA and protein expression of COX‑2, IL‑1β, and TNFR1. Treatment with BBR down‑regulated the expression levels of PGE2 and TNF‑α, decreased the activity of LDH, and downregulated the mRNA and protein expression of COX‑2, IL‑1β, and TNFR1. Taken together, the present results suggested that BBR suppressed the inflammatory response induced by Aβ25‑35 in neuroblastoma cells. The mechanism of action may be associated with the inhibition of proinflammatory factors.

View Figures

View References

1	Chen HZ, Lin GW and Wang JY: Practice of Internal Medicine. 14th. People's Medical Publishing House; Beijing: 2017, View Article : Google Scholar
2	Breitner JC: NSAIDs and Alzheimer's disease: How far to generalize from trials? Lancet Neurol. 2:5272003. View Article : Google Scholar : PubMed/NCBI
3	Hung CW, Chen YC, Hsieh WL, Chiou SH and Kao CL: Ageing and neurodegenerative diseases. Ageing Res Rev. 9 Suppl 1:S36–S46. 2010. View Article : Google Scholar : PubMed/NCBI
4	Tang J, Feng Y, Tsao S, Wang N, Curtain R and Wang Y: Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations. J Ethnopharmacol. 126:5–17. 2009. View Article : Google Scholar : PubMed/NCBI
5	Xiang W, Huang XJ and Huang GX: Study of two anti-flammatory drugs treating primary type 2 diabetic. J Pract Diabetes. 7:51–52. 2011.
6	Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, Sturrock S, Buxton S, Cooper A, Markowitz S, Duran C, et al: Geneious basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics. 28:1647–1649. 2012. View Article : Google Scholar : PubMed/NCBI
7	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
8	Halliday G, Robinson SR, Shepherd C and Kril J: Alzheimer's disease and inflammation: A review of cellular and therapeutic mechanisms. Clin Exp Pharmacol Physiol. 27:1–8. 2000. View Article : Google Scholar : PubMed/NCBI
9	Zamolodchikov D and Strickland S: A possible new role for Aβ in vascular and inflammatory dysfunction in Alzheimer's disease. Thromb Res. 141 Suppl 2:S59–S61. 2016. View Article : Google Scholar : PubMed/NCBI
10	Hurtado DE, Molina-Porcel L, Iba M, Aboagye AK, Paul SM, Trojanowski JQ and Lee VM: A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an alzheimer mouse model. Am J Pathol. 177:1977–1988. 2010. View Article : Google Scholar : PubMed/NCBI
11	Ringheim GE, Szczepanik AM, Petko W, Burgher KL, Zhu SZ and Chao CC: Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex. Brain Res Mol Brain Res. 55:35–44. 1998. View Article : Google Scholar : PubMed/NCBI
12	Li Y, Liu L, Kang J, Sheng JG, Barger SW, Mrak RE and Griffin WS: Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J Neurosci. 20:149–155. 2000. View Article : Google Scholar : PubMed/NCBI
13	Sheng JG, Zhu SG, Jones RA, Griffin WS and Mrak RE: Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Exp Neurol. 163:388–391. 2000. View Article : Google Scholar : PubMed/NCBI
14	Farooqui AA: Chapter 6: Contribution of neuroinflammation in the pathogenesis of Alzheimer's disease. Neurochemical Aspects of Alzheimer's DiseaseRisk Factors, Pathogenesis, Biomarkers, and Potential Treatment Strategies. Academic Press; pp. 201–245. 2017
15	Pollak TA, Drndarski S, Stone JM, David AS, McGuire P and Abbott NJ: The blood-brain barrier in psychosis. Lancet Psychiatry. 5:79–92. 2018. View Article : Google Scholar : PubMed/NCBI
16	Zhi-you C and Yong Y: Pathway and mechanism of oxidative stress in Alzheimer's disease. J Med Coll PLA. 22:320–324. 2007. View Article : Google Scholar
17	Teeling JL and Perry VH: Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: Underlying mechanisms. Neuroscience. 158:1062–1073. 2009. View Article : Google Scholar : PubMed/NCBI
18	Giovannini MG, Scali C, Prosperi C, Bellucci A, Vannucchi MG, Rosi S, Pepeu G and Casamenti F: Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: Involvement of the p38MAPK pathway. Neurobiol Dis. 11:257–274. 2002. View Article : Google Scholar : PubMed/NCBI
19	Wang X, Wang R, Xing D, Su H, Ma C, Ding Y and Du L: Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract. Life Sci. 77:3058–3067. 2005. View Article : Google Scholar : PubMed/NCBI
20	Kulkarni SK and Dhir A: Berberine: A plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res. 24:317–324. 2010. View Article : Google Scholar : PubMed/NCBI
21	Liu BZ, Zhang J and Yang JQ: The protective effect and mechanism of Berberine on chronic brain injury in mice induced by aluminum overload. Chin Herbal Med. 39:1351–1355. 2008.(In Chinese).
22	Lukiw WJ, Percy ME and Kruck TP: Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture. J Inorg Biochem. 99:1895–1898. 2005. View Article : Google Scholar : PubMed/NCBI
23	Babcock AA, Ilkjær L, Clausen BH, Villadsen B, Dissing-Olesen L, Bendixen AT, Lyck L, Lambertsen KL and Finsen B: Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice. Brain Behav Immun. 48:86–101. 2015. View Article : Google Scholar : PubMed/NCBI
24	Nie YH: Regulation of Interleukin-1 on β-amyloid cytotoxic and gene expression. Chin Clin Rehabilitat. 8:79–81. 2004.
25	Tseng WY, Huang YS, Lin HH, Luo SF, McCann F, McNamee K, Clanchy F and Williams R: TNFR signaling and its clinical implications. Cytokine. 101:19–25. 2018. View Article : Google Scholar
26	Mayhan WG: Cellular mechanisms by which tumor necrosis factor-alpha produces disruption of the blood-brain barrier. Brain Res. 927:144–152. 2002. View Article : Google Scholar : PubMed/NCBI
27	Keller C, Keller P, Giralt M, Hidalgo J and Pedersen BK: Exercise normalises overexpression of TNF-alpha in knockout mice. Biochem Biophys Res Commun. 321:179–182. 2004. View Article : Google Scholar : PubMed/NCBI
28	Toda K, Hayashi Y and Saibara T: Deletion of tumor necrosis factor-alpha receptor type 1 exacerbates insulin resistance and hepatic steatosis in aromatase knockout mice. Biochim Biophys Acta. 1801:655–664. 2010. View Article : Google Scholar : PubMed/NCBI
29	Mizoguchi E, Hachiya Y, Kawada M, Nagatani K, Ogawa A, Sugimoto K, Mizoguchi A and Podolsky DK: TNF receptor type I-dependent activation of innate responses to reduce intestinal damage-associated mortality. Gastroenterology. 134:470–480. 2008. View Article : Google Scholar : PubMed/NCBI
30	Schmidt N, Haydn T, Schneider I, Busch H, Boerries M and Fulda S: Smac mimetic induces an early wave of gene expression via NF-κB and AP-1 and a second wave via TNFR1 signaling. Cancer Lett. 421:170–185. 2018. View Article : Google Scholar : PubMed/NCBI
31	Vilela MC, Lima GK, Rodrigues DH, Lacerda-Queiroz N, Mansur DS, de Miranda AS, Rachid MA, Kroon EG, Vieira LQ, Campos MA, et al: TNFR1 plays a critical role in the control of severe HSV-1 encephalitis. Neurosci Lett. 479:58–62. 2010. View Article : Google Scholar : PubMed/NCBI
32	Huang LX, Yin BJ and Wang J: Sealing action of TNFRI blocking peptide-hIgGFc fusion protein and TNFRI blocking peptide on the biological effect induced by TNF-α. Chin J Immunol. 24:776–780. 2008.
33	Stanimirovic D, Shapiro A, Wong J, Hutchison J and Durkin J: The induction of ICAM-1 in human cerebromicrovascular endothelial cells (HCEC) by ischemia-like conditions promotes enhanced neutrophil/HCEC adhesion. J Neuroimmunol. 76:193–205. 1997. View Article : Google Scholar : PubMed/NCBI
34	Candelario-Jalil E, González-Falcón A, García-Cabrera M, León OS and Fiebich BL: Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats. J Neurochem. 100:1108–1120. 2007. View Article : Google Scholar : PubMed/NCBI
35	Takadera T and Ohyashiki T: Prostaglandin E2 deteriorates N-methyl-D-aspartate receptor-mediated cytotoxicity possibly by activating EP2 receptors in cultured cortical neurons. Life Sci. 78:1878–1883. 2006. View Article : Google Scholar : PubMed/NCBI